Literature DB >> 2926393

Further physicochemical characterization of the novel human brain protein h3.

F Bollengier1, S Beeckmans, A Mahler, L Kanarek.   

Abstract

Recently we reported the isolation and partial biochemical characterization of the novel polypeptide h3 from human brain and liver. In this report, the physicochemical characterization is further established by the use of several analytical methods. The following results were obtained: the ultraviolet absorption spectrum is not influenced by pH, and the circular dichroism (CD) spectrum reveals that this protein has no alpha-helices, whereas approximately 25% of the polypeptide chain is found to be folded as a beta-pleated sheet structure. Neither the conformation of h3 as assessed by CD nor the titration kinetics of sulfhydryl groups with Ellman's reagent are affected by the presence of the ions K+, Na+, Ca2+, and Mg2+. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in a beta-mercaptoethanol gradient and Cleveland sequential SDS-PAGE showed that the frequent formation of h3 polymers and doublets, as observed earlier, is almost exclusively due to disulfide bonding.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926393     DOI: 10.1111/j.1471-4159.1989.tb01856.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  2 in total

1.  Amino acid sequence of the Homo sapiens brain 21-23-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues.

Authors:  N Seddiqi; F Bollengier; P M Alliel; J P Périn; F Bonnet; S Bucquoy; P Jollès; F Schoentgen
Journal:  J Mol Evol       Date:  1994-12       Impact factor: 2.395

2.  Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.

Authors:  Katharina Deiss; Caroline Kisker; Martin J Lohse; Kristina Lorenz
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.